PYYX · Pyxus International, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $555.91M | $482.42M | $443.19M | $551.00M | $661.86M | $490.91M | $403.95M | $437.27M | $535.59M | $303.15M |
| Gross Profit | $99.89M | $87.79M | $65.63M | $83.85M | $116.45M | $75.47M | $73.14M | $92.55M | $88.67M | $40.76M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $38.28M | $40.14M | $40.37M | $40.66M | $46.51M | $38.88M | $34.06M | $42.38M | $40.03M | $34.59M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $5.28M | $5.07M | $5.17M | $5.13M | - | - | $4.61M | - | - | $5.93M |
| Operating Income | $51.29M | $46.73M | $21.00M | $40.46M | $66.08M | $33.08M | $36.42M | $47.76M | $46.29M | $6.95M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $10.30M | $10.30M | $5.23M | $6.12M | $18.09M | $8.04M | $2.65M | $6.16M | $7.56M | ($867.0K) |
| Net Income | $16.90M | ($879.0K) | ($15.82M) | $4.64M | $18.90M | ($3.23M) | $804.0K | $3.83M | $8.10M | ($14.66M) |
| EPS - Basic | $0.65 | ($0.03) | ($0.62) | $0.18 | $0.74 | ($0.12) | $0.03 | $0.15 | $0.32 | ($0.59) |
| EPS - Diluted | $0.65 | ($0.03) | ($0.62) | $0.18 | $0.74 | ($0.12) | $0.03 | $0.15 | $0.32 | ($0.59) |
Balance Sheet
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $129.84M | $99.24M | $96.44M | $92.57M | $103.34M | $123.49M | $136.73M | $90.25M | $112.10M | $198.78M |
| Accounts Receivable | $246.81M | $195.36M | $206.61M | $189.24M | $326.64M | $226.38M | $168.76M | $227.53M | $233.68M | $185.35M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $136.69M | $134.16M | $124.34M | $132.87M | $169.81M | $152.59M | $181.25M | $136.40M | $153.15M | $170.29M |
| Current Assets | $1.57B | $1.63B | $1.59B | $1.16B | $1.39B | $1.49B | $1.31B | $1.26B | $1.38B | $1.22B |
| Total Assets | $1.92B | $1.98B | $1.94B | $1.50B | $1.72B | $1.84B | $1.66B | $1.60B | $1.74B | $1.58B |
| Current Liabilities | $1.18B | $1.26B | $1.22B | $773.95M | $999.83M | $1.10B | $905.16M | $765.45M | $904.42M | $715.06M |
| Long-term Debt | $455.53M | $455.31M | $455.09M | $454.85M | $454.64M | $489.47M | $497.73M | $574.08M | $573.96M | $618.43M |
| Total Liabilities | $1.75B | $1.83B | $1.79B | $1.34B | $1.55B | $1.69B | $1.51B | $1.44B | $1.59B | $1.44B |
| Stockholders' Equity | $161.25M | $145.88M | $148.00M | $160.09M | $161.92M | $146.18M | $142.28M | $153.52M | $145.77M | $137.85M |
| Retained Earnings | ($239.93M) | ($256.83M) | ($255.95M) | ($240.13M) | ($234.98M) | ($253.88M) | ($255.29M) | ($245.22M) | ($249.06M) | ($257.95M) |
Cash Flow
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($495.29M) | ($252.18M) | - | - | ($285.67M) | - | - | ($242.49M) |
| Investing Cash Flow | - | - | $37.64M | $27.95M | - | - | $27.04M | - | - | $47.03M |
| Financing Cash Flow | - | - | $474.48M | $214.30M | - | - | $227.38M | - | - | $168.75M |
| CapEx | - | - | $4.28M | $5.10M | - | - | $3.66M | - | - | $2.21M |
| Free Cash Flow | - | - | ($499.57M) | ($257.27M) | - | - | ($289.33M) | - | - | ($244.70M) |
Ratios
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | 31.57 | -55.42 | - | - | -359.87 | - | - | 16.69 |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 37.9% | 109.3% | - | 56.9% | 48.9% | 167.0% | 76.7% | 61.6% | 48.3% | - |
| Return on assets | 0.9% | -0.0% | -0.8% | 0.3% | 1.1% | -0.2% | 0.0% | 0.2% | 0.5% | -0.9% |
| Return on equity | 10.5% | -0.6% | -10.7% | 2.9% | 11.7% | -2.2% | 0.6% | 2.5% | 5.6% | -10.6% |
| Return on invested capital | 5.2% | 3.9% | 2.8% | 3.3% | 5.5% | 2.6% | 2.8% | 3.3% | 3.3% | 0.7% |
| Liquidity | ||||||||||
| Current ratio | 1.32 | 1.30 | 1.31 | 1.50 | 1.39 | 1.35 | 1.45 | 1.64 | 1.53 | 1.71 |
| Quick ratio | 1.32 | 1.30 | 1.31 | 1.50 | 1.39 | 1.35 | 1.45 | 1.64 | 1.53 | 1.71 |
| Cash ratio | 0.11 | 0.08 | 0.08 | 0.12 | 0.10 | 0.11 | 0.15 | 0.12 | 0.12 | 0.28 |
| Leverage | ||||||||||
| Debt / Equity | 2.83 | 3.12 | 3.08 | 2.84 | 2.81 | 3.35 | 3.50 | 3.74 | 3.94 | 4.49 |
| Debt / Assets | 0.24 | 0.23 | 0.23 | 0.30 | 0.26 | 0.27 | 0.30 | 0.36 | 0.33 | 0.39 |
| Debt / EBITDA | 8.05 | 8.79 | 17.39 | 9.98 | - | - | 12.13 | - | - | 48.01 |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 11.90 | 13.55 | 13.11 | 9.39 | 10.62 | 12.56 | 11.65 | 10.43 | 11.95 | 11.48 |
| Liabilities / Assets | 0.91 | 0.92 | 0.92 | 0.89 | 0.90 | 0.92 | 0.91 | 0.90 | 0.91 | 0.91 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | 90d | 102d | 102d | 88d | 94d | 113d | 164d | 114d | 104d | 205d |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 5.4x | - | - | 22.2x | 3.7x | - | 100.0x | 11.0x | 3.7x | - |
| P / B | 0.6x | 0.6x | 0.9x | 0.6x | 0.4x | 0.5x | 0.5x | 0.3x | 0.2x | 0.2x |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | 7.4x | 8.6x | 18.8x | 10.2x | - | - | 10.6x | - | - | 34.9x |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | -14.2% | 16.3% | -21.7% | 14.6% | 25.8% | -14.9% | 79.5% | 5.4% | 31.7% | -3.2% |
| Operating income growth (YoY) | -22.4% | 41.3% | -48.1% | 11.1% | 38.4% | -28.5% | 423.8% | 14.8% | 70.6% | -15.3% |
| Net income growth (YoY) | -10.6% | 72.8% | - | 477.4% | 392.8% | - | - | - | - | -27.4% |
| EPS growth (YoY) | -12.2% | 75.0% | - | 500.0% | 393.3% | - | - | - | - | -28.3% |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | -69.4% | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | -94.2% | 11.1% | - | - | -18.2% | - | - | -28.9% |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -0.4% | -0.2% | -7.6% | 12.5% | 5.5% | 0.3% | 3.2% | 0.7% | -3.1% | -21.4% |
Peer comparison
Same SIC group: Wholesale-Farm Product Raw Materials
Comparing PYXUS INTERNATIONAL against the 4 most active filers in the same SIC group.